Visiopharm A/S, which develops software for image analysis of cells for use in cancer diagnostics, has secured a larger investment for further growth. Thus, ATP invests DKK 45m, Vækstfonden DKK 20m and CL Davids Fond DKK 15m. In addition, the existing investor, Northcap Venture Partners, has invested another 15 million.
